3 - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Developing new drugs for Tourette syndrome

3
Neurocrine received a Breakthrough Therapy Designation for this indication, and has already submitted a New Drug Application (NDA). Credit: Courtesy of Sanofi Pasteur